{"DataElement":{"publicId":"8177571","version":"1","preferredName":"Minimal Residual Disease Prior Hematopoietic Cell Transplantation Assessment Status","preferredDefinition":"A textual description of the minimal residual disease status prior to the hematopoietic cell transplantation.","longName":"MRD_PRE_HSCT_STAT","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"8177570","version":"1","preferredName":"Minimal Residual Disease Prior Hematopoietic Cell Transplantation Assessment","preferredDefinition":"Remainder of a tumor or a neoplasm/cancer after primary, potentially curative therapy._Earlier in time or order._A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases._The final result of a determination of the value, significance, or extent of.","longName":"2452232v1.0:8177568v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2452232","version":"1","preferredName":"Minimal Residual Disease","preferredDefinition":"remainder of a tumor or a neoplasm/cancer after primary, potentially curative therapy.","longName":"C3896","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurable Residual Disease","conceptCode":"C3896","definition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D052842-7AD9-4FD3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-22","modifiedBy":"ONEDATA","dateModified":"2006-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"8177568","version":"1","preferredName":"Prior Hematopoietic Cell Transplantation Assessment","preferredDefinition":"Earlier in time or order.:A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases.:The final result of a determination of the value, significance, or extent of.","longName":"C25629:C15431:C25367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Hematopoietic Cell Transplantation","conceptCode":"C15431","definition":"A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25367","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDA662CB-E4F7-4F6A-E053-4EBD850A0FA6","latestVersionIndicator":"Yes","beginDate":"2022-04-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-04-27","modifiedBy":"ONEDATA","dateModified":"2022-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDA662CB-E508-4F6A-E053-4EBD850A0FA6","latestVersionIndicator":"Yes","beginDate":"2022-04-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-04-27","modifiedBy":"CLOHNES","dateModified":"2022-09-07","changeDescription":null,"administrativeNotes":"9/7/22 Released DEC per AK for COG cjl:","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3595921","version":"1","preferredName":"Minimal Residual Disease Status","preferredDefinition":"remainder of a tumor or a neoplasm/cancer after primary, potentially curative therapy._A condition or state at a particular time.","longName":"MRD_STAT","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"8","maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CA82209A-041D-186C-E040-BB89AD431DA3","beginDate":"2012-09-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-25","modifiedBy":"ONEDATA","dateModified":"2012-09-25","deletedIndicator":"No"},{"value":"Negative","valueDescription":"Negative Finding of Minimal Residual Disease","ValueMeaning":{"publicId":"3595922","version":"1","preferredName":"Negative Finding of Minimal Residual Disease","longName":"3595922","preferredDefinition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.: remainder of a tumor or a neoplasm/cancer after primary, potentially curative therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Measurable Residual Disease","conceptCode":"C3896","definition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA82209A-042A-186C-E040-BB89AD431DA3","latestVersionIndicator":"Yes","beginDate":"2012-09-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CA82209A-0443-186C-E040-BB89AD431DA3","beginDate":"2012-09-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-25","modifiedBy":"ONEDATA","dateModified":"2012-09-25","deletedIndicator":"No"},{"value":"Positive","valueDescription":"Positive Finding of Minimal Residual Disease","ValueMeaning":{"publicId":"3595923","version":"1","preferredName":"Positive Finding of Minimal Residual Disease","longName":"3595923","preferredDefinition":"An observation confirming something, such as the presence of a disease, condition, or microorganism.: remainder of a tumor or a neoplasm/cancer after primary, potentially curative therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Measurable Residual Disease","conceptCode":"C3896","definition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA82209A-0450-186C-E040-BB89AD431DA3","latestVersionIndicator":"Yes","beginDate":"2012-09-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CA82209A-0469-186C-E040-BB89AD431DA3","beginDate":"2012-09-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-25","modifiedBy":"ONEDATA","dateModified":"2012-09-25","deletedIndicator":"No"},{"value":"Indeterminate","valueDescription":"Indeterminate","ValueMeaning":{"publicId":"2558962","version":"1","preferredName":"Indeterminate","longName":"2558962","preferredDefinition":"Cannot distinguish between two or more possible values in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate","conceptCode":"C48658","definition":"Cannot distinguish between two or more possible values in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B35F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC8DE6A-166F-14F0-E053-F662850A0B9B","beginDate":"2017-05-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-05-05","modifiedBy":"ONEDATA","dateModified":"2017-05-05","deletedIndicator":"No"},{"value":"Not evaluable","valueDescription":"Unevaluable","ValueMeaning":{"publicId":"3855538","version":"1","preferredName":"Unevaluable","longName":"3855538","preferredDefinition":"Unable to be evaluated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unevaluable","conceptCode":"C62222","definition":"Unable to be evaluated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3F3FD8B-328D-C859-E040-BB89AD43580F","latestVersionIndicator":"Yes","beginDate":"2013-08-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A3572581-21C0-197F-E053-F662850A7948","beginDate":"2020-04-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-15","modifiedBy":"ONEDATA","dateModified":"2020-04-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008563","version":"1","preferredName":"Therapy Results","preferredDefinition":"the results or effects (does not include CTC Adverse Events) of therapeutic agents or procedures administered to the patient.","longName":"TX_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6690D31-4081-494A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-06","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-02-11","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3595920","version":"1","preferredName":"Minimal Residual Disease Status","preferredDefinition":"remainder of a tumor or a neoplasm/cancer after primary, potentially curative therapy.:A condition or state at a particular time.","longName":"C3896:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurable Residual Disease","conceptCode":"C3896","definition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA82209A-03F9-186C-E040-BB89AD431DA3","latestVersionIndicator":"Yes","beginDate":"2012-09-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-25","modifiedBy":"ONEDATA","dateModified":"2012-09-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA82209A-040A-186C-E040-BB89AD431DA3","latestVersionIndicator":"Yes","beginDate":"2012-09-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-25","modifiedBy":"TAYLORT","dateModified":"2020-04-15","changeDescription":"5.15.20 tmt added 1 PV for Alliance/MC. 5.5.17 Added max length and 1 PV per ECOG request. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What was the minimal residual disease status prior to the hematopoietic cell transplantation?","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"What was the pre-HCT MRD status detected by any method?","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDA68290-F622-2484-E053-4EBD850A4142","latestVersionIndicator":"Yes","beginDate":"2022-04-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-04-27","modifiedBy":"CLOHNES","dateModified":"2022-09-07","changeDescription":null,"administrativeNotes":"9/7/22 Released CDE per AK for COG cjl;","unresolvedIssues":null,"deletedIndicator":"No"}}